DoxorubicinNo response: case report

被引：0

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1851卷 / 1期

关键词：

D O I：

10.1007/s40278-021-94228-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：138 / 138

相关论文

共 50 条

[21] UstekinumabNo response: case report [J].

Reactions Weekly, 2022, 1905 (1) :492-492

[22] MethylprednisoloneNo response: case report [J].

Reactions Weekly, 2022, 1919 (1) :376-376

[23] AdenosineNo response: case report [J].

Reactions Weekly, 2021, 1877 (1) :16-16

[24] ErdafitinibNo response : case report [J].

Reactions Weekly, 2023, 1943 (1) :309-309

[25] LorazepamNo response: case report [J].

Reactions Weekly, 2023, 1939 (1) :285-285

[26] NatalizumabNo response: case report [J].

Reactions Weekly, 2021, 1865 (1) :328-328

[27] GabapentinNo response: case report [J].

Reactions Weekly, 2021, 1875 (1) :147-147

[28] DexamethasoneNo Response: case report [J].

Reactions Weekly, 2023, 1981 (1) :152-152

[29] AntineoplasticsNo response: case report [J].

Reactions Weekly, 2022, 1895 (1) :55-55

[30] AdapaleneNo response: case report [J].

Reactions Weekly, 2021, 1848 (1) :27-27

← 1 2 3 4 5 →